Document Detail


Uncertain times for oral anticoagulation therapy.
MedLine Citation:
PMID:  15998924     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Edith A Nutescu; Ann K Wittkowsky; William E Dager
Related Documents :
2648674 - The combination of surgery and radiation in the treatment of cancer. a review.
15349834 - Pain control by ionizing radiation of bone metastasis.
12382784 - Solid state microdosimetry in hadron therapy.
7865444 - Another look at pterygium surgery with postoperative beta radiation.
24527194 - Effect of pulsed radiofrequency neuromodulation on clinical improvements in the patient...
24165464 - Abdominal mondor's disease presenting as acute abdominal pain.
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists     Volume:  62     ISSN:  1079-2082     ISO Abbreviation:  Am J Health Syst Pharm     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-07-06     Completed Date:  2005-11-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9503023     Medline TA:  Am J Health Syst Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1449     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Anticoagulants / administration & dosage,  adverse effects*
Azetidines / administration & dosage,  adverse effects*
Benzylamines
Drug Approval*
Humans
Risk
United States
United States Food and Drug Administration
Warfarin / adverse effects
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Azetidines; 0/Benzylamines; 0/ximelagatran; 81-81-2/Warfarin
Comments/Corrections
Comment On:
Am J Health Syst Pharm. 2005 Jul 15;62(14):1451-67   [PMID:  15998925 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The MicrobesOnline Web site for comparative genomics.
Next Document:  Ximelagatran: an orally active direct thrombin inhibitor.